共 28 条
[1]
[Anonymous], HIV DRUG RES REP
[2]
[Anonymous], 2012, Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
[3]
Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations
[J].
VIRUSES-BASEL,
2020, 12 (06)
[4]
Development and Application of Performance Assessment Criteria for Next-Generation Sequencing-Based HIV Drug Resistance Assays
[J].
VIRUSES-BASEL,
2020, 12 (06)
[6]
Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework
[J].
VIRUSES-BASEL,
2020, 12 (06)
[7]
DeLong AK, 2012, AIDS RES HUM RETROV, V28, P894, DOI [10.1089/aid.2011.0120, 10.1089/AID.2011.0120]
[8]
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing
[J].
VIRUSES-BASEL,
2020, 12 (12)
[9]
Are We Ready for NGS HIV Drug Resistance Testing? The Second "Winnipeg Consensus" Symposium
[J].
VIRUSES-BASEL,
2020, 12 (06)
[10]
External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations
[J].
VIRUSES-BASEL,
2020, 12 (05)